Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
for
AML, MDS
Location: Milwaukee WI, Detroit MI, Nashville TN, Baltimore MD,
Sponsor: TScan Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07702578
Phase3, Recruiting
MitoQ to Improve Vascular Funciton in Preeclampsia
for
Preeclampsia, Pregnancy
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18 - 50
Code: NCT07229261
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Rochester MN,
Sponsor: CellCentric Ltd.
Sex: All
Age: 18+
Code: NCT07096778
Phase2, Recruiting
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
for
Solid Cancer
Location: Milwaukee WI, Indianapolis IN, Edgewood KY, St Louis MO,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06161025
Phase2, Phase3, Recruiting
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
for
Epithelial Ovarian Cancer, Ovarian Cancer,
Location: Milwaukee WI, Minneapolis MN, St Louis MO,
Sponsor: Imunon
Sex: Female
Age: 18+
Code: NCT06915025
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
for
Esophageal Cancer, Oesophageal Cancer, GastroEsophageal Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06906887
Phase2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Milwaukee WI, Grand Rapids MI, Rochester MN, Detroit MI,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase2, Phase3, Recruiting
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
for
Breast Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06106477
Recruiting
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
for
Myelodysplastic Syndromes
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06502145
Phase1, Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: Milwaukee WI, Evanston IL, Elk Grove Village IL,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase3, Recruiting
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
for
Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma
Location: Milwaukee WI, Iowa City IA, St Louis MO,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04040205
Phase2, Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: Milwaukee WI, Detroit MI, Rochester NY, New York NY,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase2, Phase3, Recruiting
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
for
Neutropenia
Location: Milwaukee WI, Iowa City IA, Ann Arbor MI, Cincinnati OH,
Sponsor: X4 Pharmaceuticals
Sex: All
Age: 12+
Code: NCT06056297
Phase3, Recruiting
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center